• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Blogs » The Carlat Psychiatry Blog » How to Safely Prescribe Z-Drugs

The Carlat Psychiatry Blog
The Carlat Psychiatry Blog RSS FeedRSS

Keeping psychiatry honest since 2003.
News and opinions on mental health from Dr. Carlat, the editorial team, and guest contributors.

How to Safely Prescribe Z-Drugs

August 13, 2020
There’s good reason to be careful prescribing Z-drugs. Here’s an overview of Dr. Reban Aziz’s recent article in The Carlat Addiction Treatment Report.

Safety Tips

  1. Go short-term or intermittent to reduce the potential for adverse events and withdrawal.

  2. Avoid for SUD or complex sleep disorders. 

  3. Use as last resort after considering other meds and non-medication therapies.

  4. Educate patients to prevent driving impairment, complex sleep behaviors, and overdose. 


Potential Dangers

  • Adverse drug events. Including falls, head injuries, sedation, and vertigo. Zolpidem can also increase the likelihood of fractures resulting from falls in elderly patients (Kang DY et al, J Prev Med Public Health 2012;45(4):219–226). Zolpidem was implicated in 12% of all ED visits and, in such visits, 21% of the involved individuals were 65 years or older (Hampton LM et al, JAMA Psychiatry 2014;71(9):1006–1014).

  • Dangerous complex sleep behaviors. Including overdosing, falling, getting burned, shooting themselves, and wandering outside in cold weather. From 1992 to 2019, voluntarily reported cases to the FDA indicated that Z-drugs were attributed to 66 serious cases of complex sleep behaviors, 20 of which resulted in death. (www.fda.gov/consumers/consumer-updates/taking-z-drugs-insomnia-know-risks).

  • Motor vehicle accidents. A zolpidem blood level of 50 ng/mL can increase the risk of motor vehicle accidents by inhibiting a person's driving ability. The FDA determined that a higher percentage of individuals experience morning impairment after using extended-release zolpidem than that of patients who use short-acting zolpidem (www.fda.gov/media/84992/download). 

  • Withdrawal. Prolonged usage of zolpidem is directly associated with an increased probability of withdrawal. Zolpidem is the top withdrawal offender, but all Z-drugs, including zopiclone and eszopiclone, can induce withdrawal symptoms. (Schifano F et al, Int J Neuropsychopharmacol 2019;22(4):270–277).

  • Risk of an opioid overdose. Patients who are exposed to opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics at any point are 60% more likely to overdose than patients who are only exposed to opioids. 


Want to learn more? Click here for the full article from Dr. Aziz. Not a subscriber? Join here.
Introducing Carlat Total Access Subscriptions

Complete access to every article you search on the website.

Shop For Total Access

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • AUDFB1e_CoilBound_Graphic2_transparent_sm.png

    Treating Alcohol Use Disorder: A Fact Book (2023)

    All the tools and information needed to assess and treat your patients who are struggling with...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto45285952.jpg
    Hospital Psychiatry

    Confused About Acute Confusional States? A Primer on Delirium

    Delirium is widespread among patients in ICUs and surgery units. In this podcast, we will review the workup and management of this common condition and give you tips to help...

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.